PubRank

Baha M Sibai

Author PubWeight™ 156.05‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004 14.00
2 Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 2006 7.06
3 Timing of elective repeat cesarean delivery at term and neonatal outcomes. N Engl J Med 2009 6.86
4 Decision-to-incision times and maternal and infant outcomes. Obstet Gynecol 2006 3.15
5 Frequency of uterine contractions and the risk of spontaneous preterm delivery. N Engl J Med 2002 2.78
6 Urinary placental growth factor and risk of preeclampsia. JAMA 2005 2.76
7 Fetal injury associated with cesarean delivery. Obstet Gynecol 2006 2.61
8 Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and type 2 diabetes mellitus in the mother. Hypertension 2009 2.51
9 Expectant management of severe preeclampsia at less than 27 weeks' gestation: maternal and perinatal outcomes according to gestational age by weeks at onset of expectant management. Am J Obstet Gynecol 2008 2.21
10 Development of a nomogram for prediction of vaginal birth after cesarean delivery. Obstet Gynecol 2007 2.19
11 Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia. Am J Obstet Gynecol 2006 2.15
12 Abortion, changed paternity, and risk of preeclampsia in nulliparous women. Am J Epidemiol 2003 1.91
13 Adverse perinatal outcomes are significantly higher in severe gestational hypertension than in mild preeclampsia. Am J Obstet Gynecol 2002 1.70
14 Prediction of uterine rupture associated with attempted vaginal birth after cesarean delivery. Am J Obstet Gynecol 2008 1.70
15 Delayed postpartum preeclampsia: an experience of 151 cases. Am J Obstet Gynecol 2004 1.69
16 Prediction and prevention of recurrent preeclampsia. Obstet Gynecol 2008 1.66
17 Risk of uterine rupture with a trial of labor in women with multiple and single prior cesarean delivery. Obstet Gynecol 2006 1.65
18 Timing of elective repeat cesarean delivery at term and maternal perioperative outcomes. Obstet Gynecol 2011 1.54
19 The MFMU Cesarean Registry: factors affecting the success of trial of labor after previous cesarean delivery. Am J Obstet Gynecol 2005 1.54
20 Antioxidant therapy to prevent preeclampsia: a randomized controlled trial. Obstet Gynecol 2007 1.52
21 Maternal obesity, uterine activity, and the risk of spontaneous preterm birth. Obstet Gynecol 2009 1.49
22 Risk of uterine rupture and adverse perinatal outcome at term after cesarean delivery. Obstet Gynecol 2007 1.42
23 Comparison of transverse and vertical skin incision for emergency cesarean delivery. Obstet Gynecol 2010 1.39
24 Outcomes of induction of labor after one prior cesarean. Obstet Gynecol 2007 1.34
25 Late postpartum eclampsia: a preventable disease? Am J Obstet Gynecol 2002 1.33
26 Postpartum headache: is your work-up complete? Am J Obstet Gynecol 2007 1.27
27 Failed operative vaginal delivery. Obstet Gynecol 2009 1.27
28 Vitamin C and E supplementation in women at high risk for preeclampsia: a double-blind, placebo-controlled trial. Am J Obstet Gynecol 2005 1.26
29 Comparison of maternal and infant outcomes from primary cesarean delivery during the second compared with first stage of labor. Obstet Gynecol 2007 1.24
30 Randomized clinical trial of metronidazole plus erythromycin to prevent spontaneous preterm delivery in fetal fibronectin-positive women. Obstet Gynecol 2003 1.17
31 Evaluation and management of severe preeclampsia before 34 weeks' gestation. Am J Obstet Gynecol 2011 1.16
32 Acute fatty liver of pregnancy in 3 tertiary care centers. Am J Obstet Gynecol 2005 1.16
33 Perinatal outcome in women with recurrent preeclampsia compared with women who develop preeclampsia as nulliparas. Am J Obstet Gynecol 2002 1.15
34 Perioperative morbidity and mortality among human immunodeficiency virus infected women undergoing cesarean delivery. Obstet Gynecol 2007 1.13
35 Diagnosis and management of hemolysis, elevated liver enzymes, and low platelets syndrome. Clin Perinatol 2004 1.11
36 Indications for delivery and short-term neonatal outcomes in late preterm as compared with term births. Am J Obstet Gynecol 2009 1.09
37 The MFMU Cesarean Registry: impact of time of day on cesarean complications. Am J Obstet Gynecol 2006 1.09
38 Antioxidant supplementation and premature rupture of the membranes: a planned secondary analysis. Am J Obstet Gynecol 2008 1.08
39 Blood transfusion and cesarean delivery. Obstet Gynecol 2006 1.08
40 Less-tight versus tight control of hypertension in pregnancy. N Engl J Med 2015 1.07
41 Maternal and neonatal outcomes of repeat cesarean delivery in women with a prior classical versus low transverse uterine incision. Am J Perinatol 2010 1.07
42 Preeclampsia: Diagnosis and management of the atypical presentation. J Matern Fetal Neonatal Med 2006 1.06
43 Is bacterial vaginosis a stronger risk factor for preterm birth when it is diagnosed earlier in gestation? Am J Obstet Gynecol 2005 1.06
44 Severe sepsis and septic shock in pregnancy. Obstet Gynecol 2012 1.05
45 The MFMU Cesarean Registry: uterine atony after primary cesarean delivery. Am J Obstet Gynecol 2005 1.02
46 Can a prediction model for vaginal birth after cesarean also predict the probability of morbidity related to a trial of labor? Am J Obstet Gynecol 2008 1.02
47 Pregnancy outcomes for women with placenta previa in relation to the number of prior cesarean deliveries. Obstet Gynecol 2007 1.00
48 The frequency and complication rates of hysterectomy accompanying cesarean delivery. Obstet Gynecol 2009 1.00
49 Perioperative antibiotic prophylaxis for nonlaboring cesarean delivery. Obstet Gynecol 2009 1.00
50 Time course of the regression of asymptomatic bacterial vaginosis in pregnancy with and without treatment. Am J Obstet Gynecol 2004 0.99
51 Does information available at admission for delivery improve prediction of vaginal birth after cesarean? Am J Perinatol 2009 0.97
52 Expectant management in pregnancies with severe pre-eclampsia. Semin Perinatol 2009 0.97
53 Previous preterm cesarean delivery and risk of subsequent uterine rupture. Obstet Gynecol 2008 0.96
54 The MFMU Cesarean Registry: impact of fetal size on trial of labor success for patients with previous cesarean for dystocia. Am J Obstet Gynecol 2006 0.96
55 Labor outcomes with increasing number of prior vaginal births after cesarean delivery. Obstet Gynecol 2008 0.95
56 Smoking before pregnancy and risk of gestational hypertension and preeclampsia. Am J Obstet Gynecol 2002 0.94
57 Seizures in pregnancy: epilepsy, eclampsia, and stroke. Semin Perinatol 2013 0.94
58 Does peripartum infection increase the incidence of cerebral palsy in extremely low birthweight infants? Am J Obstet Gynecol 2007 0.93
59 Timing of delivery and adverse outcomes in term singleton repeat cesarean deliveries. Obstet Gynecol 2013 0.92
60 Elective repeat cesarean delivery compared with spontaneous trial of labor after a prior cesarean delivery: a propensity score analysis. Am J Obstet Gynecol 2012 0.92
61 Trial of labor or repeat cesarean delivery in women with morbid obesity and previous cesarean delivery. Obstet Gynecol 2006 0.91
62 Elective delivery at 34⁰(/)⁷ to 36⁶(/)⁷ weeks' gestation and its impact on neonatal outcomes in women with stable mild gestational hypertension. Am J Obstet Gynecol 2011 0.91
63 Use and misuse of the term "elective" in obstetrics. Obstet Gynecol 2011 0.90
64 Increased risk of preeclampsia among nulliparous pregnant women with idiopathic hematuria. Am J Obstet Gynecol 2002 0.89
65 Maternal and uteroplacental hemodynamics for the classification and prediction of preeclampsia. Hypertension 2008 0.88
66 Mirror syndrome: a novel approach to therapy with fetal peritoneal-amniotic shunt. Obstet Gynecol 2007 0.87
67 Salivary progesterone and estriol among pregnant women treated with 17-alpha-hydroxyprogesterone caproate or placebo. Am J Obstet Gynecol 2008 0.87
68 Thrombophilia and severe preeclampsia: time to screen and treat in future pregnancies? Hypertension 2005 0.86
69 Severe sepsis and septic shock in pregnancy: indications for delivery and maternal and perinatal outcomes. J Matern Fetal Neonatal Med 2012 0.86
70 Second-trimester asynchronous multifetal delivery results in poor perinatal outcome. Obstet Gynecol 2004 0.85
71 Preeclampsia: an inflammatory syndrome? Am J Obstet Gynecol 2004 0.85
72 Chronic Hypertension in Pregnancy: Diagnosis, Management, and Outcomes. Clin Obstet Gynecol 2017 0.84
73 Does progesterone treatment influence risk factors for recurrent preterm delivery? Obstet Gynecol 2005 0.84
74 The Maternal-Fetal Medicine Unit cesarean registry: trial of labor with a twin gestation. Am J Obstet Gynecol 2005 0.83
75 Cost-effectiveness of trial of labor after previous cesarean in a minimally biased cohort. Am J Perinatol 2013 0.83
76 The relationship between resolution of asymptomatic bacterial vaginosis and spontaneous preterm birth in fetal fibronectin-positive women. Am J Obstet Gynecol 2007 0.83
77 Expectant management of severe preeclampsia: proper candidates and pregnancy outcome. Clin Obstet Gynecol 2005 0.83
78 Intergenerational factors: a missing link for preeclampsia, fetal growth restriction, and cardiovascular disease? Hypertension 2008 0.83
79 Cervical dilatation on presentation for preterm labor and subsequent preterm birth. Am J Perinatol 2008 0.83
80 Mode of delivery in women with antepartum fetal death and prior cesarean delivery. Am J Perinatol 2010 0.82
81 Benefits and risks of expectant management of severe preeclampsia at less than 26 weeks gestation: the impact of gestational age and severe fetal growth restriction. Am J Obstet Gynecol 2011 0.82
82 Subsequent pregnancy outcome in women with a history of HELLP syndrome at < or = 28 weeks of gestation. Am J Obstet Gynecol 2003 0.82
83 Heat shock protein 70 is not increased in women with severe preeclampsia. Hypertens Pregnancy 2002 0.82
84 The coexistence of gestational hypertension and diabetes: influence on pregnancy outcome. Am J Perinatol 2008 0.82
85 Thrombophilia and adverse maternal-perinatal outcome. Clin Obstet Gynecol 2006 0.81
86 Lifetime cost-effectiveness of trial of labor after cesarean in the United States. Value Health 2013 0.81
87 Progesterone for the prevention of preterm birth: indications, when to initiate, efficacy and safety. Ther Clin Risk Manag 2009 0.81
88 Risk of uterine rupture and placenta accreta with prior uterine surgery outside of the lower segment. Obstet Gynecol 2012 0.81
89 Tocolysis in women with preterm labor between 32 0/7 and 34 6/7 weeks of gestation: a randomized controlled pilot study. Am J Obstet Gynecol 2006 0.81
90 The Role of Headache in the Classification and Management of Hypertensive Disorders in Pregnancy. Obstet Gynecol 2015 0.81
91 Expectant management of severe preeclampsia at 27(0/7) to 33(6/7) weeks' gestation: maternal and perinatal outcomes according to gestational age by weeks at onset of expectant management. Am J Perinatol 2009 0.81
92 Dexamethasone to improve maternal outcome in women with hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Obstet Gynecol 2005 0.81
93 A prospective masked observational study of uterine contraction frequency in twins. Am J Obstet Gynecol 2006 0.81
94 Defining standards of care in maternal-fetal medicine. Am J Obstet Gynecol 2004 0.81
95 Are perinatal and maternal outcomes different during expectant management of severe preeclampsia in the presence of intrauterine growth restriction? Am J Obstet Gynecol 2007 0.81
96 Maternal-Fetal Medicine Units Network cesarean registry: impact of shift change on cesarean complications. Am J Obstet Gynecol 2008 0.81
97 Does an obese prepregnancy body mass index influence outcome in pregnancies complicated by mild gestational hypertension remote from term? Am J Obstet Gynecol 2005 0.80
98 Mild gestational hypertension: differences in ethnicity are associated with altered outcomes in women who undergo outpatient treatment. Am J Obstet Gynecol 2002 0.80
99 The effect of body mass index on therapeutic response to bacterial vaginosis in pregnancy. Am J Perinatol 2008 0.80
100 Temporising versus interventionist management (preterm and at term). Best Pract Res Clin Obstet Gynaecol 2011 0.79
101 Management of hypertensive disorders in pregnancy. Womens Health (Lond Engl) 2014 0.78
102 Biomarker for hypertension-preeclampsia: are we close yet? Am J Obstet Gynecol 2007 0.78
103 Magnesium sulfate in women with mild preeclampsia: a randomized controlled trial. Obstet Gynecol 2003 0.78
104 Cesarean delivery for the second twin. Obstet Gynecol 2008 0.78
105 Sexual intercourse association with asymptomatic bacterial vaginosis and Trichomonas vaginalis treatment in relationship to preterm birth. Am J Obstet Gynecol 2002 0.78
106 Gastrointestinal complications of pre-eclampsia. Semin Perinatol 2009 0.78
107 Preterm labor biomarker discovery in serum using 3 proteomic profiling methodologies. Am J Obstet Gynecol 2009 0.77
108 Can postgraduate courses in Maternal-Fetal Medicine change clinical attitude? J Matern Fetal Neonatal Med 2005 0.77
109 Effect of antenatal corticosteroids on respiratory morbidity in singletons after late-preterm birth. Obstet Gynecol 2012 0.77
110 Neonatal and infant outcomes in twin gestations with preterm premature rupture of membranes at 24-31 weeks of gestation. Obstet Gynecol 2014 0.77
111 Prenatal education is an opportunity for improved outcomes in hypertensive disorders of pregnancy: results from an Internet-based survey. J Matern Fetal Neonatal Med 2013 0.77
112 HELLP syndrome: an atypical presentation. Am J Obstet Gynecol 2008 0.77
113 Maternal and perinatal outcome in women with a history of stroke. Am J Obstet Gynecol 2004 0.77
114 Diagnosis and Management of HELLP Syndrome Complicated by Liver Hematoma. Clin Obstet Gynecol 2017 0.77
115 Antenatal corticosteroids impact the inflammatory rather than the antiangiogenic profile of women with preeclampsia. Hypertension 2014 0.76
116 Demographic and obstetric factors influencing pregnancy outcome in twin gestations. Am J Obstet Gynecol 2002 0.76
117 Caring for women with hypertension in pregnancy. JAMA 2007 0.76
118 The effect of fetal number on the development of hypertensive conditions of pregnancy. Obstet Gynecol 2005 0.76
119 The impact of medically indicated and spontaneous preterm birth among hypertensive women. Am J Perinatol 2013 0.76
120 Angiogenic and Antiangiogenic Markers for Prediction and Risk Classification of Preeclampsia. Clin Obstet Gynecol 2017 0.76
121 Antioxidant supplementation in pre-eclampsia. Lancet 2006 0.75
122 The magpie trial. Lancet 2002 0.75
123 White's classification of maternal diabetes and vaginal birth after cesarean delivery success in women undergoing a trial of labor. Obstet Gynecol 2010 0.75
124 Induction of labour improves maternal outcomes compared with expectant monitoring in women with gestational hypertension or mild pre-eclampsia. Evid Based Med 2010 0.75
125 Elevated plasma homocysteine in early pregnancy: a risk factor for the development of severe preeclampsia. Am J Obstet Gynecol 2002 0.75
126 Disparity in the rate of eclampsia and adverse pregnancy outcome from eclampsia: a tale of two countries. Obstet Gynecol 2011 0.75
127 Intraumbilical vein injection of oxytocin and the third stage of labor: randomized double-blind placebo trial. Am J Perinatol 2007 0.75
128 Counseling, Management, and Outcome in Women With Severe Preeclampsia at 23 to 28 Weeks' Gestation. Clin Obstet Gynecol 2017 0.75
129 Controversies Regarding Diagnosis and Treatment of Severe Hypertension in Pregnancy. Clin Obstet Gynecol 2017 0.75
130 Antenatal Corticosteroids for the Prevention of Respiratory Distress Syndrome in Premature Twins. Obstet Gynecol 2016 0.75
131 Trial of labor after one previous cesarean delivery for multifetal gestation. Obstet Gynecol 2007 0.75
132 Association of Nonsteroidal Antiinflammatory Drugs and Postpartum Hypertension in Women With Preeclampsia With Severe Features. Obstet Gynecol 2017 0.75
133 Uterine contraction frequency before and after successful tocolytic therapy for preterm uterine contractions. J Reprod Med 2003 0.75
134 Thrombophilia and adverse maternal-perinatal outcome: controversies in screening and management. Am J Perinatol 2006 0.75
135 Corticosteroids effect on caspase 3 expression in an in-vitro model of hypoxic brain cells. J Matern Fetal Neonatal Med 2013 0.75
136 Early Compared With Delayed Physician Rounds on Patient Satisfaction of Postpartum Women: A Randomized Controlled Trial. Obstet Gynecol 2016 0.75
137 17-alphahydroxyprogesterone caproate in women with previous spontaneous preterm delivery: does a previous term delivery affect the rate of recurrence? Am J Obstet Gynecol 2011 0.75
138 Severe pre-eclampsia and maternal health. Introduction. Semin Perinatol 2009 0.75
139 Life-threatening emergencies in preeclampsia-eclampsia. J Ky Med Assoc 2006 0.75
140 Low-Molecular-Weight Heparin for the Prevention of Placenta-mediated Pregnancy Complications. Clin Obstet Gynecol 2017 0.75
141 An initial Glasgow score of 4 and Apgar scores of 9 and 9: a case report of a pregnant comatose woman. Am J Obstet Gynecol 2003 0.75